We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Hernia Repair Using Anchored Mesh Can Carry Major Risks

By HospiMedica International staff writers
Posted on 07 Feb 2012
Surgeons should use caution when anchoring mesh to the diaphragm, following 15 cases of cardiac tamponade caused by the procedure, including eight deaths. More...


Researchers at the Chicago Institute of Minimally Invasive Surgery (Skokie, IL, USA) conducted a search of the US Food and Drug Administration (FDA) manufacturer and user device experience (MAUDE) database and the PubMed Medline database to identify 15 distinct cases of cardiac injury during hernia repair using mesh anchored to the diaphragm. Ten of these were during hiatal hernia repair, resulting in six deaths, and five in ventral hernia repair, four of which were fatal. The researchers also reported on two previously unpublished cases.

The study revealed that the most common cause of injury was helical tacks, accounting for 10 of the 15 injuries; two further injuries were caused by sutures, one by a straight stapler, and the rest from unknown causes. Helical tacks, made from titanium wire about 4 mm long, are often delivered in the tissue blindly and, after thinning the tissue, are deployed completely before ejecting the tack. Thus, the tack is advanced into the tissue with the leading edge penetrating beyond visualization; If the tack is fired into tissue less than a minimum of 4 mm thick, injury to an underlying organ, such as the pericardium, heart, or intestines is possible. The study was published ahead of print on September 25, 2011, in Surgery.

“Anchoring mesh to the diaphragm is not to be taken lightly, regardless of the type of mesh being used. The careless placement of sutures, staples, and especially the helical tacker may result in a catastrophic injury to the heart,” concluded study authors Constantine Frantzides, MD, PhD, and Scott Welle, DO. “Only with appropriate awareness and recognition can this catastrophic complication be avoided.”

Cardiac tamponade is a compression of the heart that occurs when blood or fluid builds up in the space between the myocardium and the pericardium. This prevents the ventricles from expanding fully, and the excess pressure from the fluid prevents the heart from functioning normally. The initial symptoms of tamponade, which include tachycardia and hypotension, can be mistaken for more common complications, such as pulmonary embolism (PE), heart failure, and myocardial infarction (MI). The authors also noted that clinical manifestation of tamponade could present at any time postoperatively, even as late as 14 days.

Related Links:

Chicago Institute of Minimally Invasive Surgery



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.